Severe COVID-19 increases the risk of schizophrenia.
Psychiatry Res
; 317: 114809, 2022 Nov.
Article
in English
| MEDLINE | ID: covidwho-2251205
ABSTRACT
The coronavirus SARS-CoV-2 invades the central nervous system, impacting the mental health of COVID-19 patients. We performed a two-sample Mendelian randomization analysis to assess the potential causal effects of COVID-19 on schizophrenia. Our analysis indicated that genetic liability to hospitalized COVID-19 was associated with an increased risk for schizophrenia (OR 1.11, 95% CI 1.02-1.20, P = 0.013). However, genetic liability to SARS-CoV-2 infection was not associated with the risk of schizophrenia (1.06, 0.83-1.37, P = 0.643). Severe COVID-19 was associated with an 11% increased risk for schizophrenia, suggesting that schizophrenia should be assessed as one of the post-COVID-19 sequelae.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Schizophrenia
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Psychiatry Res
Year:
2022
Document Type:
Article
Affiliation country:
J.psychres.2022.114809
Similar
MEDLINE
...
LILACS
LIS